Variant report
Variant | nsv981310 |
---|---|
Chromosome Location | chr6:11689104-11694850 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:11685508..11687716-chr6:11690185..11693002,2 | MCF-7 | breast: | |
2 | chr6:11691117..11693663-chr6:11695839..11698577,2 | K562 | blood: | |
3 | chr6:11685812..11688101-chr6:11689840..11692824,2 | K562 | blood: | |
4 | chr6:11690358..11691945-chr6:12011366..12013423,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000095951 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578232561 | chr6:11689136-11689137 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540664374 | chr6:11689148-11689149 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566510601 | chr6:11689155-11689156 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9394243 | chr6:11689162-11689163 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs549123580 | chr6:11689181-11689182 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557554761 | chr6:11689185-11689186 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560284690 | chr6:11689208-11689209 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78348276 | chr6:11689217-11689218 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12216511 | chr6:11689242-11689243 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs372089024 | chr6:11689254-11689255 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190391572 | chr6:11689261-11689262 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142211043 | chr6:11689296-11689297 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553998734 | chr6:11689311-11689312 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9469853 | chr6:11689312-11689313 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs9394244 | chr6:11689344-11689345 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs6941343 | chr6:11689477-11689478 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs576168098 | chr6:11689497-11689498 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146188953 | chr6:11689505-11689506 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138993839 | chr6:11689507-11689508 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572587612 | chr6:11689536-11689537 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10947520 | chr6:11689537-11689538 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs9462005 | chr6:11689629-11689630 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs528902083 | chr6:11689639-11689640 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548960085 | chr6:11689643-11689644 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551690125 | chr6:11689706-11689707 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112825571 | chr6:11689707-11689708 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551435683 | chr6:11689713-11689714 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571367669 | chr6:11689734-11689735 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148632634 | chr6:11689915-11689916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114198825 | chr6:11689923-11689924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182079776 | chr6:11689960-11689961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565022483 | chr6:11689967-11689968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115226240 | chr6:11689976-11689977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556183219 | chr6:11690010-11690011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34578559 | chr6:11690074-11690075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34098751 | chr6:11690078-11690079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs199715835 | chr6:11690079-11690080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200621094 | chr6:11690084-11690085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201444136 | chr6:11690085-11690086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199894110 | chr6:11690087-11690088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs6931662 | chr6:11690105-11690106 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs11754457 | chr6:11690111-11690112 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs558978733 | chr6:11690115-11690116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs61681578 | chr6:11690116-11690117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138220700 | chr6:11690145-11690146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs72122693 | chr6:11690146-11690147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs75125264 | chr6:11690147-11690148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386697138 | chr6:11690148-11690149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12199757 | chr6:11690153-11690154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs62395208 | chr6:11690162-11690163 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 21183584 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:11685000-11689400 | Enhancers | Fetal Intestine Large | intestine |
2 | chr6:11685200-11693000 | Weak transcription | Spleen | Spleen |
3 | chr6:11686600-11701400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr6:11686600-11702400 | Weak transcription | HSMMtube | muscle |
5 | chr6:11687200-11689200 | Enhancers | Fetal Heart | heart |
6 | chr6:11687200-11689200 | Enhancers | Fetal Stomach | stomach |
7 | chr6:11687200-11689400 | Enhancers | Brain Germinal Matrix | brain |
8 | chr6:11688600-11689200 | Enhancers | Fetal Kidney | kidney |
9 | chr6:11688600-11689200 | Enhancers | Fetal Lung | lung |
10 | chr6:11688600-11689400 | Enhancers | Fetal Intestine Small | intestine |
11 | chr6:11688600-11689400 | Enhancers | Ovary | ovary |
12 | chr6:11688800-11692600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr6:11688800-11711000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
14 | chr6:11689000-11689800 | Strong transcription | HSMM | muscle |
15 | chr6:11689200-11692800 | Weak transcription | Fetal Heart | heart |
16 | chr6:11689800-11702000 | Weak transcription | HSMM | muscle |
17 | chr6:11690000-11690800 | Enhancers | HUVEC | blood vessel |
18 | chr6:11690800-11693000 | Weak transcription | HUVEC | blood vessel |
19 | chr6:11692400-11692800 | Active TSS | Duodenum Mucosa | Duodenum |
20 | chr6:11692400-11693200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr6:11692600-11693200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr6:11692800-11693400 | ZNF genes & repeats | Primary hematopoietic stem cells short term culture | blood |
23 | chr6:11693000-11693200 | Enhancers | Aorta | Aorta |
24 | chr6:11693000-11693400 | Enhancers | Spleen | Spleen |
25 | chr6:11693000-11694400 | Enhancers | HUVEC | blood vessel |